Literature DB >> 12792479

Corneal endothelial cell damage from glaucoma drainage device materials.

K Sheng Lim1.   

Abstract

PURPOSE: To compare the level of endothelial damage caused by contact with materials used in contemporary glaucoma drainage devices and a phosphorylcholine polymer-coated PMMA (PC-PMMA). METHODS Standard-sized discs of silicone, PMMA (polymethylmethacrylate), and PC-PMMA (n = 6) were gently lowered onto cultured bovine corneal endothelial (BCE) monolayers using a vacuum suction device. A 2.4-g stainless steel cloning ring weight was then placed on top of each disc. The weights and discs were removed using a vacuum suction device and forceps after 5 minutes of contact. A 0.4% trypan blue solution was used to stain the cell monolayer to visualize the area of cell damage. The total area of damage in each well (including the area stripped of cells) was measured using an image processor and expressed as a percentage of the total disc area to derive a damage coefficient for each material. Damage coefficients for different materials were compared using Bonferroni corrected analysis of variance (ANOVA).
RESULTS: Percentage of areas of damage (mean +/- SD) after standardized contact were as follows: PMMA, 5.95 +/- 4.60%; silicone, 3.08 +/- 2.68%; PC-PMMA, 0.15 +/- 0.25%. PMMA caused marked endothelial cell damage. PC-PMMA discs produced a significantly lower level (p = 0.04) of endothelial cell trauma.
CONCLUSION: Our results suggest that PC coating technology may be effective in reducing the rate of corneal endothelial failure following GDD implantation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12792479     DOI: 10.1097/00003226-200305000-00013

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  8 in total

1.  Clinical outcomes of trabeculectomy versus Ahmed glaucoma valve implantation in patients with penetrating keratoplasty.

Authors:  Halil Ates; Melis Palamar; Ayse Yagci; Sait Egrilmez
Journal:  Int Ophthalmol       Date:  2016-01-22       Impact factor: 2.031

2.  Mini drug pump for ophthalmic use.

Authors:  Saloomeh Saati; Ronalee Lo; Po-Ying Li; Ellis Meng; Rohit Varma; Mark S Humayun
Journal:  Trans Am Ophthalmol Soc       Date:  2009-12

3.  Outcome of Descemet stripping automated endothelial keratoplasty in eyes with an Ahmed glaucoma valve.

Authors:  Patrick J Chiam; Robert Cheeseman; Vivian W Ho; Vito Romano; Anshoo Choudhary; Mark Batterbury; Stephen B Kaye; Colin E Willoughby
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-03-17       Impact factor: 3.117

4.  Mini drug pump for ophthalmic use.

Authors:  Saloomeh Saati; Ronalee Lo; Po-Ying Li; Ellis Meng; Rohit Varma; Mark S Humayun
Journal:  Curr Eye Res       Date:  2010-03       Impact factor: 2.424

5.  Corneal Endothelial Transplantation in Uveitis: Incidence and Risk Factors.

Authors:  Ana M Roldan; Nazlee Zebardast; Maxwell Pistilli; Naira Khachatryan; Abhishek Payal; Hosne Begum; Pichaporn Artornsombudh; Siddharth S Pujari; James T Rosenbaum; H Nida Sen; Eric B Suhler; Jennifer E Thorne; Nirali P Bhatt; C Stephen Foster; Douglas A Jabs; Grace A Levy-Clarke; Robert B Nussenblatt; Jeanine M Buchanich; John H Kempen
Journal:  Am J Ophthalmol       Date:  2021-11-13       Impact factor: 5.258

Review 6.  Graft failure: III. Glaucoma escalation after penetrating keratoplasty.

Authors:  Emily C Greenlee; Young H Kwon
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

Review 7.  Microinvasive glaucoma surgery: a review and classification of implant-dependent procedures and techniques.

Authors:  Joanna Jabłońska; Katarzyna Lewczuk; Joanna Konopińska; Zofia Mariak; Marek Rękas
Journal:  Acta Ophthalmol       Date:  2021-05-14       Impact factor: 3.988

8.  Prospective Randomized Study Comparing Combined Phaco-ExPress and Phacotrabeculectomy in Open Angle Glaucoma Treatment: 12-Month Follow-Up.

Authors:  Joanna Konopińska; Marta Deniziak; Emil Saeed; Agnieszka Bartczak; Renata Zalewska; Zofia Mariak; Marek Rękas
Journal:  J Ophthalmol       Date:  2015-06-07       Impact factor: 1.909

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.